Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

1.46
Delayed Data
As of Aug 31
 -0.31 / -17.51%
Today’s Change
0.72
Today|||52-Week Range
2.64
+51.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues23.0K27.0K39.0K15.0K
 
 
 
 
 
Cost of Goods Sold61.0K5.0K134.0K163.0K
 
 
 
 
 
Depreciation And Amortization292.0K361.0K330.0K316.0K
 
 
 
 
 
 
Operating ExpensesGross Income-330.0K-339.0K-425.0K-464.0K
 
 
 
 
 
General Expenses3.7M2.5M3.3M2.4M
 
 
 
 
 
Research And Development2.0M957.0K1.0M900.0K
 
 
 
 
 
Total Operating Expenses4.0M2.9M3.7M2.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-2.8M-3.7M-2.8M
 
 
 
 
 
Extraordinary Credit0.000.0031.0K1.5M
 
 
 
Interest Expense On Debt1.0K0.000.000.00
 
 
Other Expenses0.000.001.5M20.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.8M-3.1M-2.2M-1.3M
 
 
 
 
 
Net Income-3.8M-3.1M-2.2M-1.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS246.8M247.6M247.6M248.0M
 
 
 
 
 
Shares To Calculate EPS Diluted246.8M247.6M247.6M248.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.01-$0.01-$0.01
 
 
 
 
 
EPS Diluted-$0.02-$0.01-$0.01-$0.01